Market Research Logo

Amicus Therapeutics, Inc. - Product Pipeline Review - 2015

Amicus Therapeutics, Inc. - Product Pipeline Review - 2015

Summary

Global Markets Direct’s, ‘Amicus Therapeutics, Inc. - Product Pipeline Review - 2015’, provides an overview of the Amicus Therapeutics, Inc.’s pharmaceutical research and development focus.

This report provides comprehensive information on the current therapeutic developmental pipeline of Amicus Therapeutics, Inc.’s, complete with comparative analysis at various stages, therapeutics assessment by drug target, mechanism of action (MoA), route of administration (RoA) and molecule type. It also reviews latest updates, and featured news and press releases, along with special features on late-stage and discontinued projects.

Global Markets Direct’s report features investigational drugs from across globe covering over 20 therapy areas and nearly 3,000 indications. The report is built using data and information sourced from Global Markets Direct’s proprietary databases, Company/University websites, SEC filings, investor presentations and featured press releases from company/university sites and industry-specific third party sources, put together by Global Markets Direct’s team. Drug profiles/records featured in the report undergoes periodic updation following a stringent set of processes that ensures that all the profiles are updated with the latest set of information. Additionally, processes including live news & deals tracking, browser based alert-box and clinical trials registries tracking ensure that the most recent developments are captured on a real time basis.

The report enhances decision making capabilities and help to create effective counter strategies to gain competitive advantage. It strengthens R&D pipelines by identifying new targets and MOAs to produce first-in-class and best-in-class products.

Note*: Certain sections in the report may be removed or altered based on the availability and relevance of data for the indicated disease.

Scope

  • The report provides brief overview of Amicus Therapeutics, Inc. including business description, key information and facts, and its locations and subsidiaries
  • The report reviews current pipeline of Amicus Therapeutics, Inc.’s human therapeutic division and enlists all their major and minor projects
  • The report features product description and descriptive mechanism of action for key pipeline products along with the product’s developmental history and major milestones
  • Special feature on out-licensed and partnered product portfolio
  • The report summarizes all the dormant and discontinued pipeline projects
  • Latest company statement
  • Latest news and deals relating to the Amicus Therapeutics, Inc.’s pipeline products
Reasons to buy
  • Evaluate Amicus Therapeutics, Inc.’s strategic position with total access to detailed information on its product pipeline
  • Assess the growth potential of Amicus Therapeutics, Inc. in its therapy areas of focus
  • Identify new drug targets and therapeutic classes in the Amicus Therapeutics, Inc.’s R&D portfolio and develop key strategic initiatives to reinforce pipeline in those areas
  • Exploit in-licensing opportunities by identifying windows of opportunity to fill portfolio gaps
  • Develop strategic initiatives by understanding the focus areas of Amicus Therapeutics, Inc. and exploit collaboration and partnership opportunities
  • Identify emerging players with potentially strong product portfolio and create effective counter-strategies to gain competitive advantage
  • Plan mergers and acquisitions effectively by identifying the most promising pipeline of Amicus Therapeutics, Inc.
  • Develop and design in-licensing and out-licensing strategies by identifying prospective partners with the most attractive projects to enhance and expand business potential and scope
  • Explore the dormant and discontinued projects of Amicus Therapeutics, Inc. and identify potential opportunities in those areas
  • Avoid Intellectual Property Rights related issues


Amicus Therapeutics, Inc. Snapshot
Amicus Therapeutics, Inc. Overview
Key Information
Key Facts
Amicus Therapeutics, Inc. - Research and Development Overview
Key Therapeutic Areas
Amicus Therapeutics, Inc. - Pipeline Review
Pipeline Products by Stage of Development
Pipeline Products - Monotherapy
Pipeline Products - Combination Treatment Modalities
Pipeline Products - Partnered Products
Partnered Products/Combination Treatment Modalities
Amicus Therapeutics, Inc. - Pipeline Products Glance
Amicus Therapeutics, Inc. - Late Stage Pipeline Products
Pre-Registration Products/Combination Treatment Modalities
Phase III Products/Combination Treatment Modalities
Amicus Therapeutics, Inc. - Clinical Stage Pipeline Products
Phase II Products/Combination Treatment Modalities
Amicus Therapeutics, Inc. - Early Stage Pipeline Products
Preclinical Products/Combination Treatment Modalities
Amicus Therapeutics, Inc. - Drug Profiles
migalastat hydrochloride
Product Description
Mechanism of Action
R&D Progress
(migalastat hydrochloride + agalsidase alfa)
Product Description
Mechanism of Action
R&D Progress
duvoglustat hydrochloride + alglucosidase alfa
Product Description
Mechanism of Action
R&D Progress
(duvoglustat hydrochloride + ATB-200)
Product Description
Mechanism of Action
R&D Progress
afegostat tartrate
Product Description
Mechanism of Action
R&D Progress
afegostat tartrate + ERT
Product Description
Mechanism of Action
R&D Progress
AT-3375
Product Description
Mechanism of Action
R&D Progress
ATB-200
Product Description
Mechanism of Action
R&D Progress
Chaperone-ERT Combinations
Product Description
Mechanism of Action
R&D Progress
laronidase + chaperone
Product Description
Mechanism of Action
R&D Progress
migalastat hydrochloride + Enzyme Replacement Therapy Biobetter
Product Description
Mechanism of Action
R&D Progress
Recombinant Enzyme for Lysosomal Storage Disorder
Product Description
Mechanism of Action
R&D Progress
Small Molecule for Neurodegenerative Diseases
Product Description
Mechanism of Action
R&D Progress
Amicus Therapeutics, Inc. - Pipeline Analysis
Amicus Therapeutics, Inc. - Pipeline Products by Target
Amicus Therapeutics, Inc. - Pipeline Products by Route of Administration
Amicus Therapeutics, Inc. - Pipeline Products by Molecule Type
Amicus Therapeutics, Inc. - Pipeline Products by Mechanism of Action
Amicus Therapeutics, Inc. - Recent Pipeline Updates
Amicus Therapeutics, Inc. - Dormant Projects
Amicus Therapeutics, Inc. - Company Statement
Amicus Therapeutics, Inc. - Locations And Subsidiaries
Head Office
Other Locations & Subsidiaries
Appendix
Methodology
Coverage
Secondary Research
Primary Research
Expert Panel Validation
Contact Us
Disclaimer
List of Tables
Amicus Therapeutics, Inc., Key Information
Amicus Therapeutics, Inc., Key Facts
Amicus Therapeutics, Inc. - Pipeline by Indication, 2015
Amicus Therapeutics, Inc. - Pipeline by Stage of Development, 2015
Amicus Therapeutics, Inc. - Monotherapy Products in Pipeline, 2015
Amicus Therapeutics, Inc. - Combination Treatment Modalities in Pipeline, 2015
Amicus Therapeutics, Inc. - Partnered Products in Pipeline, 2015
Amicus Therapeutics, Inc. - Partnered Products/ Combination Treatment Modalities, 2015
Amicus Therapeutics, Inc. - Pre-Registration, 2015
Amicus Therapeutics, Inc. - Phase III, 2015
Amicus Therapeutics, Inc. - Phase II, 2015
Amicus Therapeutics, Inc. - Preclinical, 2015
Amicus Therapeutics, Inc. - Pipeline by Target, 2015
Amicus Therapeutics, Inc. - Pipeline by Route of Administration, 2015
Amicus Therapeutics, Inc. - Pipeline by Molecule Type, 2015
Amicus Therapeutics, Inc. - Pipeline Products by Mechanism of Action, 2015
Amicus Therapeutics, Inc. - Recent Pipeline Updates, 2015
Amicus Therapeutics, Inc. - Dormant Developmental Projects,2015
Amicus Therapeutics, Inc., Subsidiaries
List of Figures
Amicus Therapeutics, Inc. - Pipeline by Top 10 Indication, 2015
Amicus Therapeutics, Inc. - Pipeline by Stage of Development, 2015
Amicus Therapeutics, Inc. - Monotherapy Products in Pipeline, 2015
Amicus Therapeutics, Inc. - Combination Treatment Modalities in Pipeline, 2015
Amicus Therapeutics, Inc. - Pipeline by Top 10 Target, 2015
Amicus Therapeutics, Inc. - Pipeline by Top 10 Route of Administration, 2015
Amicus Therapeutics, Inc. - Pipeline by Top 10 Molecule Type, 2015
Amicus Therapeutics, Inc. - Pipeline Products by Top 10 Mechanism of Action, 2015

Download our eBook: How to Succeed Using Market Research

Learn how to effectively navigate the market research process to help guide your organization on the journey to success.

Download eBook

Share this report